Glossary and FAQ
Explore key terms about Fagron and the pharmaceutical industry, and answers to frequently asked questions.
Pharmaceutical industry
| Term | Definition |
|---|---|
|
503A
|
Compounding pharmacy that delivers personalized medication to patients on a script-by-script basis
|
|
503B
|
Large facility that produces compounding medication to hospitals and clinics and produces in bulk
|
|
CAPA
|
Corrective and Preventive Actions
|
|
API
|
Active Pharmaceutical Ingredient
|
|
Excipients
|
Functional ingredients used in compounding formulations
|
|
CADE
|
Conselho Administrativo de Defesa Econômica – Brazil’s antitrust authority
|
|
BHRT
|
Bioidentical Hormone Replacement Therapies - personalized supplementation therapies designed to optimize hormone levels as part of a health and wellness approach focused on prevention
|
|
Form 483
|
Observation letter from FDA following an inspection, naming articles where the inspection has detected breaches
|
|
GMP
|
Good Manufacturing Practice – standard required to manufacture medication to ensure quality, safety and efficacy
|
|
cGMP
|
Current Good Manufacturing Practice – manufacturers use up-to-date technologies and systems
|
|
IV
|
Intravenous
|
|
OTC
|
Over the counter – it can be purchased without a prescription from a doctor
|
|
Clean room
|
Where compounded medicine is produced and raw materials are repackaged
|
|
Out of pocket
|
Medication that is not subject to be reimbursed to the patient
|
|
CMO
|
Contract Manufacturing Organization
|
|
GLP-1
|
Glucagon-like peptide-1
|
Frequently Asked Questions
Fagron’s shares are listed at Euronext Brussels and Euronext Amsterdam.
ISIN: BE0003874915
Symbol: FAGR
You can find the total number of shares outstanding here.
- Fagron does not sell shares directly to the public. You will need to approach a licensed stockbroker to acquire our shares.
Fagron pays its dividend once per year in May, three days after the ex-dividend date. Ex-dividend date: 18 May 2026.
Fagron does not have a dividend re-investment plan.
Fagron’s next AGM is scheduled for 11 May 2026. You can find more information about the AGM here.
You can find information about our main shareholders here.
Please reach out to us here.
Information on this page was most recently updated on 15 April 2026.